Leukemia Clinical Trials in North Carolina

Showing 801-809 of 809 trials

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

NCT00066885

This Phase 1/2 clinical trial is a multi-center, open-label study with three main objectives. The first (Phase 1A) is to determine the maximum-tolerated dose of DN-101 when administered in combination with Taxotere (docetaxel) every three weeks (closed). The second is to determine the maximum-tolerated dose of DN-101 when administered weekly in combination with Taxotere(docetaxel)devery three weeks (open). The third is to evaluate the safety and objective tumor response rate of the combination in NSCLC. DN-101 doses will be escalated at three dosing levels. Patients will receive oral DN-101 on day one, followed by intravenous docetaxel on day two of a 21-day cycle. Treatment cycles will be repeated at the same dose level each 21 days until disease progression or unacceptable toxicity.

Carcinoma, Non-Small-Cell Lung

Novacea80 participantsStarted Jun 2003

Berkeley, California, United States • Vallejo, California, United States • Denver, Colorado, United States +8 more locations

COMPLETEDPHASE241 miles

Amonafide in Combination With Cytarabine in Secondary AML

NCT00273884

This protocol is designed to assess the safety and efficacy of amonafide in combination with cytarabine in subjects with previously untreated secondary AML.

Acute Myeloid Leukemia

Xanthus Pharmaceuticals, Inc.80 participantsStarted Aug 2005

Birmingham, Alabama, United States • Duarte, California, United States • Los Angeles, California, United States +18 more locations

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Amonafide in Combination With Cytarabine in Secondary AML

Leukemia Trials in Other Cities

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

CP-481,715 Nickel Allergy Study.

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Other Conditions in North Carolina